These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 37913604

  • 1. Use of physical examination, electrocardiography, radiography, and biomarkers to predict echocardiographic stage B2 myxomatous mitral valve disease in preclinical Cavalier King Charles Spaniels.
    Wesselowski S, Gordon SG, Fries R, Saunders AB, Sykes KT, Vitt J, Boutet B, Häggström J, Kadotani S, Stack J, Barnett BG.
    J Vet Cardiol; 2023 Dec; 50():1-16. PubMed ID: 37913604
    [Abstract] [Full Text] [Related]

  • 2. The prevalence of pulmonary hypertension in Cavalier King Charles spaniels compared with other breeds with myxomatous mitral valve disease.
    Sudunagunta S, Green D, Christley R, Dukes-McEwan J.
    J Vet Cardiol; 2019 Jun; 23():21-31. PubMed ID: 31174726
    [Abstract] [Full Text] [Related]

  • 3. Heart rate, heart rate variability, and arrhythmias in dogs with myxomatous mitral valve disease.
    Rasmussen CE, Falk T, Zois NE, Moesgaard SG, Häggström J, Pedersen HD, Ablad B, Nilsen HY, Olsen LH.
    J Vet Intern Med; 2012 Jun; 26(1):76-84. PubMed ID: 22151356
    [Abstract] [Full Text] [Related]

  • 4. Prediction of clinically important acquired cardiac disease without an echocardiogram in large breed dogs using a combination of clinical, radiographic and electrocardiographic variables.
    Wesselowski S, Gordon SG, Meddaugh N, Saunders AB, Häggström J, Cusack K, Janacek BW, Matthews DJ.
    J Vet Cardiol; 2022 Apr; 40():126-141. PubMed ID: 34483077
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Urine 5-hydroxyindoleacetic acid in Cavalier King Charles spaniels with preclinical myxomatous mitral valve disease.
    Christiansen LB, Cremer SE, Helander A, Madsen T, Reimann MJ, Møller JE, Höglund K, Ljungvall I, Häggström J, Olsen LH.
    Vet J; 2019 Aug; 250():36-43. PubMed ID: 31383418
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Prospective pilot study on the predictive significance of plasma miR-30b-5p through the study of echocardiographic modifications in Cavalier King Charles Spaniels affected by different stages of myxomatous mitral valve disease: The PRIME study.
    Ghilardi S, Lecchi C, Bagardi M, Romito G, Colombo FM, Polli M, Franco C, Brambilla PG.
    PLoS One; 2022 Aug; 17(12):e0274724. PubMed ID: 36574372
    [Abstract] [Full Text] [Related]

  • 10. Comparison of N-terminal pro-atrial natriuretic peptide and three cardiac biomarkers for discriminatory ability of clinical stage in dogs with myxomatous mitral valve disease.
    Ogawa M, Hori Y, Kanno N, Iwasa N, Toyofuku T, Isayama N, Yoshikawa A, Akabane R, Sakatani A, Miyakawa H, Hsu HH, Miyagawa Y, Takemura N.
    J Vet Med Sci; 2021 Apr 24; 83(4):705-715. PubMed ID: 33551383
    [Abstract] [Full Text] [Related]

  • 11. Comparison of cellular changes in Cavalier King Charles spaniel and mixed breed dogs with myxomatous mitral valve disease.
    Lu CC, Liu MM, Culshaw G, French A, Corcoran B.
    J Vet Cardiol; 2016 Jun 24; 18(2):100-9. PubMed ID: 26860643
    [Abstract] [Full Text] [Related]

  • 12. Influence of Morphometry on Echocardiographic Measurements in Cavalier King Charles Spaniels: An Inverse Probability Weighting Analysis.
    Bagardi M, Ghilardi S, Locatelli C, Bionda A, Polli M, Bussadori CM, Colombo FM, Pazzagli L, Brambilla PG.
    Vet Sci; 2021 Sep 23; 8(10):. PubMed ID: 34679035
    [Abstract] [Full Text] [Related]

  • 13. Echocardiographic measurement of the mitral valve in normal Cavalier King Charles spaniels: repeatability, optimal future study methods, and preliminary reference intervals.
    Wesselowski S, Saunders AB, Werre S, Gordon SG.
    J Vet Cardiol; 2022 Oct 23; 43():81-92. PubMed ID: 36099705
    [Abstract] [Full Text] [Related]

  • 14. Predictive value of natriuretic peptides in dogs with mitral valve disease.
    Tarnow I, Olsen LH, Kvart C, Hoglund K, Moesgaard SG, Kamstrup TS, Pedersen HD, Häggström J.
    Vet J; 2009 May 23; 180(2):195-201. PubMed ID: 18675567
    [Abstract] [Full Text] [Related]

  • 15. Circulating MiR-30b-5p is upregulated in Cavalier King Charles Spaniels affected by early myxomatous mitral valve disease.
    Bagardi M, Ghilardi S, Zamarian V, Ceciliani F, Brambilla PG, Lecchi C.
    PLoS One; 2022 May 23; 17(7):e0266208. PubMed ID: 35816500
    [Abstract] [Full Text] [Related]

  • 16. Clinical and Echocardiographic Findings in an Aged Population of Cavalier King Charles Spaniels.
    Prieto Ramos J, Corda A, Swift S, Saderi L, De La Fuente Oliver G, Corcoran B, Summers KM, French AT.
    Animals (Basel); 2021 Mar 28; 11(4):. PubMed ID: 33800666
    [Abstract] [Full Text] [Related]

  • 17. The predictive value of clinical, radiographic, echocardiographic variables and cardiac biomarkers for assessing risk of the onset of heart failure or cardiac death in dogs with preclinical myxomatous mitral valve disease enrolled in the DELAY study.
    Borgarelli M, Ferasin L, Lamb K, Chiavegato D, Bussadori C, D'Agnolo G, Migliorini F, Poggi M, Santilli RA, Guillot E, Garelli-Paar C, Toschi Corneliani R, Farina F, Zani A, Dirven M, Smets P, Guglielmini C, Oliveira P, Di Marcello M, Porciello F, Crosara S, Ciaramella P, Piantedosi D, Smith S, Vannini S, Dall'Aglio E, Savarino P, Quintavalla C, Patteson M, Silva J, Locatelli C, Baron Toaldo M.
    J Vet Cardiol; 2021 Aug 28; 36():77-88. PubMed ID: 34118562
    [Abstract] [Full Text] [Related]

  • 18. N-terminal pro-B-type natriuretic peptide levels in normotensive and hypertensive dogs with myxomatous mitral valve disease stage B.
    Jang IS, Yoon WK, Choi EW.
    Ir Vet J; 2023 Feb 08; 76(1):3. PubMed ID: 36755290
    [Abstract] [Full Text] [Related]

  • 19. Utility of radiographic measurements to predict echocardiographic left heart enlargement in dogs with preclinical myxomatous mitral valve disease.
    Poad MH, Manzi TJ, Oyama MA, Gelzer AR.
    J Vet Intern Med; 2020 Sep 08; 34(5):1728-1733. PubMed ID: 32686167
    [Abstract] [Full Text] [Related]

  • 20. Echocardiographic Evaluation of the Mitral Valve in Cavalier King Charles Spaniels.
    Bagardi M, Bionda A, Locatelli C, Cortellari M, Frattini S, Negro A, Crepaldi P, Brambilla PG.
    Animals (Basel); 2020 Aug 19; 10(9):. PubMed ID: 32825079
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.